Priority Date: 19.09.05 (FR 20050009528)

ASSOCIATION OF ss3 RECEPTOR AGONIST AND MONOAMINE REUPTAKE INHIBITORS, PHARMACEUTICAL COMPOSITION AND THERAPEUTIC USE THEREOF

  • Application ID: EP06808148
  • Status: No opposition filed within time limit

Attorneys

no operation time available
2 offices
Technology Company
no operation time available
2 offices
Technology Company

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Sanofi is specialized in A61. Sanofi, Sanofi-Aventis is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 19.09.2005 - Priority Date (FR 20050009528)
  • 29.03.2007 - Publication A1 (WO2007034056)
  • 11.06.2008 - Publication A1 (EP1928448)
  • 02.09.2009 - Publication B1 (EP1928448)